trial · primary record
Cobimetinib
Langerhan's Cell Histiocytosis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 90 |
| Primary completion | 2029-12 |
| Primary endpoint | Overall Response Rates using modified RECiST criteria |
| Registry ID | NCT04079179 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:51.488Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04079179
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.